Cargando…
Recent advances in systemic therapy. New diagnostics and biological predictors of outcome in early breast cancer
The key to optimising our approach in early breast cancer is to individualise care. Each patient has a tumour with innate features that dictate their chance of relapse and their responsiveness to treatment. Often patients with similar clinical and pathological tumours will have markedly different ou...
Autores principales: | Oakman, Catherine, Bessi, Silvia, Zafarana, Elena, Galardi, Francesca, Biganzoli, Laura, Di Leo, Angelo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2688942/ https://www.ncbi.nlm.nih.gov/pubmed/19435470 http://dx.doi.org/10.1186/bcr2238 |
Ejemplares similares
-
Significance of Micrometastases: Circulating Tumor Cells and Disseminated Tumor Cells in Early Breast Cancer
por: Oakman, Catherine, et al.
Publicado: (2010) -
Role of lapatinib in the first-line treatment of patients with metastatic breast cancer
por: Oakman, Catherine, et al.
Publicado: (2010) -
The best treatment for older patients with breast cancer
por: Turner, Natalie, et al.
Publicado: (2013) -
Circulating Biomarkers of CDK4/6 Inhibitors Response in Hormone Receptor Positive and HER2 Negative Breast Cancer
por: Migliaccio, Ilenia, et al.
Publicado: (2021) -
Recent Advancements on the Use of Exosomes as Drug Carriers for the Treatment of Glioblastoma
por: Galardi, Angela, et al.
Publicado: (2023)